Obesity and cardiovascular disease: is body structure a factor?

Related Experiment Videos

S Nielsen1, M D Jensen

  • 1Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

Insights

Abdominal obesity increases cardiovascular risks. Weight loss can significantly improve these health risks associated with excess abdominal fat.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Obesity is a major risk factor for cardiovascular disease.
  • Abdominal obesity, particularly visceral fat, is linked to adverse health outcomes.
  • Associated conditions include atherogenic lipid profiles and insulin resistance.

Purpose of the Study:

  • To highlight the link between abdominal obesity and cardiovascular risks.
  • To discuss the metabolic and hemostatic abnormalities associated with visceral fat.
  • To emphasize the benefits of weight loss in mitigating these risks.

Main Methods:

  • Review of existing literature on obesity and cardiovascular health.
  • Analysis of the relationship between fat distribution and metabolic markers.
  • Assessment of the impact of weight reduction on cardiovascular risk factors.

Main Results:

  • Abdominal obesity is strongly correlated with increased cardiovascular morbidity and mortality.
  • Visceral fat accumulation is associated with atherogenic lipid profiles, insulin resistance, and hemostatic abnormalities.
  • Weight loss interventions demonstrate improvements in cardiovascular risk factors.

Conclusions:

  • Abdominal obesity poses a significant threat to cardiovascular health.
  • Targeting visceral fat through weight loss is crucial for reducing atherothrombotic risk.
  • Managing obesity is key to preventing cardiovascular complications.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...